Prostate cancer is the most common form of cancer in males and accounts for high cancer related deaths. Therapeutic advancement in prostate cancer has not been able to reduce the mortality burden of prostate cancer, which warrants further research. | Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion